Has anyone read the CMS proposed rule Implementing Anti-Fraud Provisions of the health care reform Law ? Where CMS is proposing to consider any publicly traded DMEPOS provider to be considered low risk for fraud, but, any currently enrolled, non publicly traded provider as moderate risk for fraud, with regulations and controls levied accordingly!
Can anyone explain how such a blatantly short sighted, arbitrary piece of proposed legislation has made it even this far in CMS system ? Makes one wonder who’s controlling who.
Please read the news letter from AOPA concerning this proposed rule and be sure to send in your comments to CMS before the November 16 2010 deadline.
Dale Anderson CPO
West Coast Prosthetics & Orthotics
2102-E Carriage Dr SW
Suite 102
Olympia, WA. 98502
